Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: Performances of three different media assessed by using E- test and National Committee for Clinical Laboratory Standards M27-A methodologies

Journal of Clinical Microbiology

Volumn 36, Issue 10, 1998, Pages 2817-2822

  Lozano Chiu, M ^a,c   Paetznick, V L ^a   Ghannoum, M A ^b   Rex, J H ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B;

AGAR GEL DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIUM; FUNGUS CULTURE; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL;

CANDIDA; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 0031685148     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.10.2817-2822.1998     Document Type: Article

References (41)

1. Anaissie, E., and G. P. Bodey. 1989. Nosocomial fungal infections: old problems and new challenges. Infect. Dis. Clin. N. Am. 3:867-882.
2. Anaissie, E., R. Shawar, V. Paetznick, L. G. Ensign, Z. Witte, and M. LaRocco. 1993. Two-site comparison of broth microdilution and semisolid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media. J. Clin. Microbiol. 31:1370-1372.
3. Anaissie, E. J., V. L. Paetznick, L. G. Ensign, A. Espinel-Ingroff, J. N. Galgiani, C. A. Hitchcock, M. LaRocco, T. Patterson, M. A. Pfaller, J. H. Rex, and M. G. Rinaldi. 1996. Microdilution antifungal susceptibility testing of Candida and Cryptococcus neoformans with and without agitation: an eight-center collaborative study. Antimicrob. Agents Chemother. 40:2387-2391.
4. Berenguer, J., V. Fernandez-Baca, R. Sanchez, and E. Bouza. 1995. In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections. Eur. J. Clin. Microbiol. Infect. Dis. 14:362-365.
5. Block, E. R., A. E. Jennings, and J. E. Bennett. 1973. Variables influencing susceptibility testing of Cryptococcus neooformans to 5-fluorocytosine. Antimicrob. Agents Chemother. 4:392-395.
6. Bottone, E. J., I. E. Salkin, N. J. Hurd, and G. P. Wormser. 1987. Serogroup distribution of Cryptococcus neoformans in patients with AIDS. J. Infect. Dis. 156:242.
7. Bozzette, S. A., R. A. Larsen, J. Chiu, M. A. E. Leal, J. Jacobsen, P. Rothman, P. Robinson, G. Gilbert, J. A. McCutchan, J. Tilles, J. M. Leedom, D. D. Richman, and The California Collaborative Treatment Group. 1991. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 324:580-584.
8. Calhoun, D. L., and J. N. Galgiani. 1984. Analysis of pH and buffer effects on flucylosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media. Antimicrob. Agents Chemother. 26:364-367.
9. Del Poeta, M., F. Barchiesi, D. Arzeni, G. Marinucci, and G. Scalise. 1994. Turbidimetric and visual criteria for in vitro susceptibility testing of Cryptococcus neoformans clinical isolates. Mycoses 37:411-416.
10. Del Poeta, M., F. Barchiesi, V. Morbiducci, D. Arzeni, G. Marinucci, F. Ancarani, and G. Scalise. 1994. Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans. J. Chemother. 6:173-176.
11. Franzot, S. P., and J. S. Hamdan. 1996. In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs. Antimicrob. Agents Chemother. 40:822-824.
12. Fromtling, R. A., J. N. Galgiani, M. A. Pfaller, A. Espinel-Ingroff, K. F. Bartizal, M. S. Bartlett, B. A. Body, C. Frey, G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993. Multicenter evaluation of a macrobroth antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
13. Gadea, I., M. Cuenca, M. I. Gegundez, J. Zapardiel, M. L. Valero, and F. Soriano. 1997. Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts. J. Antimicrob. Chemother. 39:453-459.
14. Galgiani, J. N., and M. L. Lewis. 1997. In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrob. Agents Chemother. 41:180-183.
15. Ghannoum, M. A., A. S. Ibrahim, Y. Fu, M. C. Shafiq, J. E. Edwards, and R. S. Criddle. 1992. Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J. Clin. Microbiol. 30:2881-2886.
16. Hoeprich, P. D., and J. M. Merry. 1986. Influence of culture medium on susceptibility testing with BAY 7133 and ketoconazole. J. Clin. Microbiol. 24:269-271.
17. Joseph-Horne, T., R. S. T. Loeffler, D. W. Hollomon, and S. L. Kelly. 1996. Amphotericin B resistant isolates of Cryptococcus neoformans without alteration in sterol biosynthesis. J. Med. Vet. Mycol. 34:223-225.
18. 8-7 isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol. Lett. 122:39-42.
19. Kwon-Chung, K. J., and J. E. Bennett. 1984. Epidemiological differences between the two varieties of Cryptococcus neoformans. Am. J. Epidemiol. 120:123-130.
20. Kwon-Chung, K. J., I. Polacheck, and J. E. Bennett. 1982. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J. Clin. Microbiol. 15:535-537.
21. Larsen, R. A., S. A. Bozzette, B. E. Jones, D. Haghighat, M. A. Leal, D. Forthal, M. Bauer, J. G. Tilles, J. A. McCutchan, and J. M. Leedom. 1994. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis. 19:741-745.
22. Lozano-Chiu, M., M. A. Ghannoum, P. Belanger, and J. H. Rex. 1997. Effect of media on detection of amphotericin B (AmB)-resistant Cryptococcus neoformans, abstr. C-251, p. 164. In Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology, Washington, D.C.
23. Lozano-Chiu, M., M. A. Ghannoum, and J. H. Rex. 1997. Detection of amphotericin B (AmB)-resistant Cryptococcus neoformans is enhanced by use of Etest and/or antibiotic medium 3 (AM3), abstr. D-141, p. 108. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
24. Lozano-Chiu, M., P. W. Nelson, M. Lancaster, M. A. Pfaller, and J. H. Rex. 1997. Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B. J. Clin. Microbiol. 35:270-272.
25. Marriott, D. J. E., R. Hardiman, S. Chen, J. L. Harkness, and R. Pennry. 1996. The development of amphotericin B resistant Cryptococcus neoformans during treatment in an Australian HIV-infected patient, abstr. 3.21. In 3rd International Conference on Cryptococcus and cryptococcosis.
26. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard M27-A. National Committee tor Clinical Laboratory Standards, Wayne, Pa.
27. Nguyen, M. H., C. J. Clancy, V. L. Yu, Y. C. Yu, A. J. Morris, D. R. Snydman, D. A. Sutton, and M. G. Rinaldi. 1998. Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. J. Infect. Dis. 177:425-430.
28. Patterson, T. F., and V. T. Andriole. 1989. Current concepts in cryptococcosis. Eur. J. Clin. Microbiol. Infect. Dis. 8:457-465.
29. Perfect, J. R., D. V. Savani, and D. T. Durack. 1986. Comparison of itraconazole and fluconazole in treatment of cryplococcal meningitis and candida pyelonephritis in rabbits. Antimicrob. Agents Chemother. 29:579-583.
30. Pfaller, M. A., M. Bale, B. Buschelman, M. Lancaster. A. Espinel-Ingroff, J. H. Rex, and M. G. Rinaldi. 1994. Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods. J. Clin. Microbiol. 32:1650-1653.
31. Pfaller, M. A., and A. L. Barry. 1994. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32:1992-1996.
32. Powderly, W. G., E. J. Keath, M. Sokol-Anderson, K. Robinson, D. Kitz, J. R. Little, and G. Kobayashsi. 1992. Amphotericin B-resistant Cryptococcus neoformans in a patient with AIDS. Infect. Dis. Clin. Pract. 1:314-316.
33. Rex, J. H., C. R. Cooper, Jr., W. G. Merz, J. N. Galgiani, and E. J. Anaissie. 1995. Detection of amphotericin B-resistant Candida isolates in a broth-based system. Antimicrob. Agents Chemother. 39:906-909.
34. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, A. L. Barry, and for the Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. 1997. Development of interpretative breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole and Candida infections. Clin. Infect. Dis. 24:235-247.
35. Rinaldi, M. G., D. J. Drutz, A. Howell, M. A. Sande, C. B. Wofsy, and W. K. Hadley. 1986. Serotypes of Cryptococcus neoformans in patients with AIDS. J. Infect. Dis. 153:642.
36. Rodriguez-Tudela, J. L., and J. V. Martinez-Suarez. 1994. Improved medium for fluconazole susceptibility testing of Candida albicans. Antimicrob. Agents Chemother. 38:45-48.
37. Shimizu, R. Y., D. H. Howard, and M. N. Clancy. 1986. The variety of Cryptococcus neoformans in patients with AIDS. J. Infect. Dis. 154:1042.
38. Smith, N. H., E. A. Graviss, R. Hashmey, M. Lozano-Chiu, J. H. Rex, R. Hamill, and S. Greenberg. 1997. Multi-drug-resistant cryptococcal meningitis in an AIDS patient, abstr. 529. In 35th Annual Meeting of the Infectious Diseases Society of America.
39. Speed, B., and D. Dunt. 1995. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin. Infect. Dis. 21: 28-34.
40. Wanger, A., K. Mills, P. W. Nelson, and J. H. Rex. 1995. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob. Agents Chemother. 39:2520-2522.
41. Witt, M. D., R. J. Lewis, R. A. Larsen, E. N. Milefchik, M. A. E. Leal, R. H. Haubrich, J. A. Richie, J. J. E. Edwards, and M. A. Ghannoum. 1996. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin. Infect. Dis. 22:322-328.